Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

Gastroenterology

Volumn 120, Issue 4, 2001, Pages 806-815

  Jeppesen, Palle Bekker ^a   Hartmann, Bolette ^a   Thulesen, Jesper ^a   Graff, Jesper ^a   Lohmann, Jette ^a   Hansen, Birthe Stenbak ^a   Tofteng, Flemming ^a   Poulsen, Steen Seier ^a   Madsen, Jan Lysgaard ^a   Holst, Jens Juul ^a   Mortensen, Per Brobech ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 2;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; COLON MUCOSA; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOOD INTAKE; HUMAN; INTESTINE ABSORPTION; INTESTINE TRANSIT TIME; LEAN BODY WEIGHT; MALABSORPTION; MALE; NUTRIENT; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; STOMACH EMPTYING;

EID: 0035123108     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22555     Document Type: Article

References (41)

1. Enteroglucagon
2. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function
3. Glucagonoma syndrome demonstrating giant duodenal villi
4. Ileal glucagon gene expression: Ontogeny and response to massive small bowel resection
5. Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection
6. The hormonal pattern of intestinal adaptation. A major role for enteroglucagon
7. Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine
8. Structure, measurement, and secretion of human glucagon-like peptide-2
9. Induction of intestinal epithelial proliferation by glucagon-like peptide 2
10. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice
11. GLP-2 augments the adaptive response to massive intestinal resection in rat
12. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs
13. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2
14. Impairment of "ileostomy adaptation" in patients after ileal resection
15. Disturbed gastric emptying in the short bowel syndrome. Evidence for a "colonic brake"
16. Gastrointestinal motility considerations in patients with short-bowel syndrome
17. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure
18. Intestinal failure defined by measurements of intestinal energy and wet weight absorption
19. Simplified method for the measurement of total non-starch polysaccharides by gas-liquid chromatography of constituent sugars as alditol acetates
20. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection
21. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection
22. Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets
23. Scintigraphic evaluation of gastric emptying
24. Gastrointestinal transit of technetium-99m-labeled cellulose fiber and indium-111-labeled plastic particles
25. Quality of life in patients receiving home parenteral nutrition
26. Adult patients receiving home parenteral nutrition in Denmark from 1991 to 1996: Who will benefit from intestinal transplantation?
27. Recurrent sepsis in home parenteral nutrition patients: An analysis of risk factors
28. Superior vena caval obstruction in patients with gut failure receiving home parenteral nutrition
29. Does long-term home parenteral nutrition in adult patients cause chronic liver disease?
30. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet
31. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome
32. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled study
33. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: A randomised, double blind, crossover, placebo controlled study
34. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome
35. Nutrient regulation of intestinal growth and adaptation: Role of glucagon-like peptide 2 and the enteroendocrine cell
36. Short bowel, short answer?
37. Urinary creatinine excretion and lean body mass
38. Colon as a digestive organ in patients with short bowel
39. Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: A randomized, controlled study
40. Effect of high dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients